AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites
Clinical trial NCT02417753 · TERMINATED
Trial details
- NCT number
- NCT02417753
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-03
- Primary completion
- 2016-04-07
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.